Xingyu Wang
44 Papers
345 Citations
Xingyu Wang is an academic researcher. The author has contributed to research in topics: Medicine & Odds ratio. The author has an hindex of 26, co-authored 37 publications.
Chat about Author
Papers
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
Martin O'Donnell,Martin O'Donnell,Denis Xavier,Lisheng Liu,Hongye Zhang,Siu Lim Chin,Purnima Rao-Melacini,Sumathy Rangarajan,Shofiqul Islam,Prem Pais,Matthew J. McQueen,Charles Mondo,Albertino Damasceno,Patricio Lopez-Jaramillo,Graeme J. Hankey,Antonio L. Dans,Khalid Yusoff,Thomas Truelsen,Hans-Christoph Diener,Ralph L. Sacco,Danuta Ryglewicz,Anna Członkowska,Christian Weimar,Xingyu Wang,Salim Yusuf +24 more
TL;DR: The findings suggest that ten risk factors are associated with 90% of the risk of stroke, and targeted interventions that reduce blood pressure and smoking, and promote physical activity and a healthy diet, could substantially reduce the burden of stroke.
3.4K
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
Martin O'Donnell,Martin O'Donnell,Siu Lim Chin,Sumathy Rangarajan,Denis Xavier,Lisheng Liu,Hongye Zhang,Purnima Rao-Melacini,Xiaohe Zhang,Prem Pais,Steven Agapay,Patricio Lopez-Jaramillo,Albertino Damasceno,Peter Langhorne,Matthew J. McQueen,Annika Rosengren,Mahshid Dehghan,Graeme J. Hankey,Antonio L. Dans,Ahmed Elsayed,Alvaro Avezum,Charles Mondo,Hans-Christoph Diener,Danuta Ryglewicz,Anna Członkowska,Nana Pogosova,Christian Weimar,Romaina Iqbal,Rafael Diaz,Khalid Yusoff,Khalid Yusoff,Afzalhussein Yusufali,Aytekin Oguz,Xingyu Wang,Ernesto Peñaherrera,Fernando Lanas,Okechukwu S Ogah,Adesola Ogunniyi,Helle K. Iversen,Germán Málaga,Zvonko Rumboldt,Shahram Oveisgharan,Fawaz Al Hussain,Daliwonga Magazi,Yongchai Nilanont,John Ferguson,Guillaume Paré,Salim Yusuf +47 more
TL;DR: The importance of potentially modifiable risk factors for stroke in different regions of the world, and in key populations and primary pathological subtypes of stroke, was quantified.
1.9K
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
Johannes F.E. Mann,Roland E. Schmieder,Matthew J. McQueen,Leanne Dyal,Helmut Schumacher,Janice Pogue,Xingyu Wang,Aldo P. Maggioni,Andrzej Budaj,Suphachai Chaithiraphan,Kenneth Dickstein,Matyas Keltai,Kaj Metsärinne,Ali Oto,Alexander Parkhomenko,Leopoldo S. Piegas,Tage Lysbo Svendsen,Koon K. Teo,Salim Yusuf +18 more
TL;DR: In people at high vascular risk, telmisartan's effects on major renal outcomes are similar to ramipril, and although combination therapy reduces proteinuria to a greater extent than monotherapy, overall it worsens major renal outcome.
1.4K
•Journal Article
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study) : a multicentre, randomised, double-blind, controlled trial. Commentary
Pantelis Sarafidis,George L. Bakris,Johannes F.E. Mann,Roland E. Schmieder,Matthew J. McQueen,Leanne Dyal,Helmut Schumacher,Janice Pogue,Xingyu Wang,Aldo P. Maggioni,Andrzej Budaj,Suphachai Chaithiraphan,Kenneth Dickstein,Matyas Keltai,Kaj Metsärinne,All Oto,Alexander Parkhomenko,Leopoldo S. Piegas,Tage Lysbo Svendsen,Koon K. Teo,Salim Yusuf +20 more
TL;DR: In this article, the authors investigated the renal effects of Ramipril (an ACE inhibitor), telmisartan (an ARB), and their combination in patients aged 55 years or older with established atherosclerotic vascular disease or with diabetes with end-organ damage.
1.4K
Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events
Andrew Mente,Sumathy Rangarajan,Matthew J. McQueen,Xingyu Wang,Lisheng Liu,Hou Yan,Shun Fu Lee,Prem Mony,Anitha Devanath,Annika Rosengren,Patricio Lopez-Jaramillo,Rafael Diaz,Alvaro Avezum,Fernando Lanas,Khalid Yusoff,Rafał Ilow,Noushin Mohammadifard,Sadi Gulec,Afzalhussein Yusufali,Lanthe Kruger,Rita Yusuf,Jephat Chifamba,Conrad Kabali,Gilles R. Dagenais,Scott A. Lear,Koon K. Teo,Salim Yusuf,Abstr Act +27 more
TL;DR: An estimated sodium intake between 3g per day and 6 g per day was associated with a lower risk of death and cardiovascular events than was either a higher or lower estimated level of intake.